Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel I Simon

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyDavid E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Circulation|September 26, 2012
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working groupValentin Fuster, Deepak L Bhatt, Robert M Califf, et al.
Circulation Research|March 30, 2012
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitisHarald F Langer, Eun Young Choi, Hong Zhou, et al.
The New England Journal of Medicine|November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
JAMA|November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trialJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA|November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trialJay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyDavid E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Circulation|September 26, 2012
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working groupValentin Fuster, Deepak L Bhatt, Robert M Califf, et al.
Circulation Research|March 30, 2012
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitisHarald F Langer, Eun Young Choi, Hong Zhou, et al.
The New England Journal of Medicine|November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
JAMA|November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trialJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA|November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trialJay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Pageof 16